6.2 Insulin Formulations, Concentrations (U-100, U-500, U-200, U-300), and Pen/Vial Math
Key Takeaways
- Insulin is categorized into rapid-acting (lispro, aspart, glulisine), short-acting (Regular), intermediate-acting (NPH), and long-acting (glargine, detemir, degludec) formulations, where NPH and premixed insulins are cloudy suspensions requiring gentle inversion (never shaking).
- Standard insulin concentration is U-100 (100 units/mL), whereas concentrated insulins include Humulin R U-500 (500 units/mL), Toujeo glargine U-300 (300 units/mL), Humalog lispro U-200 (200 units/mL), and Tresiba degludec U-200 (200 units/mL).
- Humulin R U-500 is 5 times more concentrated than standard U-100 insulin; it carries an extreme risk of fatal hypoglycemia and must only be measured using a dedicated green-striped U-500 syringe or a dedicated U-500 KwikPen.
- Insulin pen devices automatically dial the prescribed units directly regardless of concentration; withdrawing insulin from an insulin pen cartridge with an external syringe is strictly prohibited due to fatal overdose miscalculations.
- Room temperature Beyond-Use Dating (BUD) varies dramatically across insulin formulations, ranging from 10 days (Humulin 70/30 pens) to 28 days (Lantus, Humalog, Novolog), 42 days (Levemir, Novolin N vials), and 56 days (Toujeo, Tresiba).
Insulin Formulations, Concentrations, and Delivery Math
Critical Verification Principle: Insulin is one of the top high-alert medications in both inpatient and outpatient pharmacy practice. An error in concentration selection (e.g., confusing U-100 with U-500), syringe type, or beyond-use dating can precipitate rapid, fatal hypoglycemic encephalopathy or severe diabetic ketoacidosis. Product verification requires absolute precision in pharmacokinetic matching, concentration verification, and device math.
Insulin is an endogenous peptide hormone essential for glucose homeostasis. In pharmacotherapy, synthetic recombinant human insulins and insulin analogs are formulated across diverse pharmacokinetic profiles and concentrations. Technicians performing product verification must master insulin kinetics, visual characteristics, specialized syringe markings, and concentrated delivery systems.
1. Pharmacokinetic Classification & Visual Appearance
Insulin products are classified based on their onset of action, peak therapeutic effect, and overall duration of activity. In addition to chemical structure, their physical visual appearance (clear solution vs. cloudy suspension) is a mandatory verification checkpoint.
| Pharmacokinetic Class | Generic Name | Brand Names | Onset | Peak Effect | Effective Duration | Visual Appearance & Handling Rules |
|---|---|---|---|---|---|---|
| Rapid-Acting | Insulin lispro<br/>Insulin aspart<br/>Insulin glulisine | Humalog, Admelog, Lyumjev<br/>Novolog, Fiasp<br/>Apidra | 10–30 min | 30–90 min | 3–5 hours | Clear solution. Administer within 15 minutes before or immediately after meals. Compatible with IV infusion (Regular preferred). |
| Short-Acting | Regular human insulin | Humulin R, Novolin R | 30–60 min | 2–4 hours | 5–8 hours | Clear solution. Administer 30 minutes prior to meals. Standard insulin of choice for continuous intravenous (IV) infusions in DKA. |
| Intermediate-Acting | NPH (Neutral Protamine Hagedorn) | Humulin N, Novolin N | 1–2 hours | 4–12 hours | 14–24 hours | Cloudy suspension. Contains protamine buffer. Must be gently rolled/inverted 10 times prior to use; NEVER shake vigorously (causes foaming and protein denaturation). Never give IV! |
| Long-Acting (Basal) | Insulin glargine<br/>Insulin detemir | Lantus, Basaglar, Semglee, Toujeo (U-300)<br/>Levemir | 1–4 hours | Relatively flat / peakless | 24 hours (Lantus)<br/>14–24 hours (Levemir) | Clear solution. Provides flat, steady baseline glucose control. NEVER mix in the same syringe with any other insulin (acidic pH causes precipitation). |
| Ultra-Long-Acting | Insulin degludec | Tresiba (U-100, U-200) | 1 hour | Peakless | >42 hours | Clear solution. Forms multi-hexamers in subcutaneous tissue for ultra-extended, flat release. |
| Premixed Combinations | NPH / Regular (70/30)<br/>Protamine / Lispro (75/25, 50/50)<br/>Protamine / Aspart (70/30) | Humulin 70/30, Novolin 70/30<br/>Humalog Mix 75/25, Humalog Mix 50/50<br/>Novolog Mix 70/30 | Dual onset (15–30 min) | Dual peak | 14–24 hours | Cloudy suspension. Combines rapid/short mealtime coverage with intermediate basal coverage. First number is intermediate protamine component; second number is rapid/short component. Must roll gently before use. |
[!IMPORTANT] The Clear vs. Cloudy Rule: All rapid-acting, short-acting (Regular), and long-acting (glargine, detemir, degludec) insulins are crystal-clear solutions. If a vial or pen of Lantus, Humalog, or Regular insulin appears cloudy, discolored, or contains particulate matter, it is degraded and must be quarantined immediately. Conversely, NPH and all premixed insulins (70/30, 75/25, 50/50) are cloudy suspensions that require gentle rolling/inversion to resuspend before drawing.
2. Standard U-100 vs. Concentrated Insulin Formulations
Historically, nearly all commercial insulins were manufactured at a standard concentration of U-100 (meaning 100 units of insulin per 1 mL of fluid). However, severely insulin-resistant patients requiring massive daily doses (often >200 units/day) require large injection volumes with U-100, causing pain, erratic subcutaneous absorption, and tissue lipohypertrophy. To address this, manufacturers developed concentrated formulations.
| Insulin Formulation | Concentration | Relative Potency vs U-100 | Volume for 50 Units | Available Delivery Devices | Primary Indication / Clinical Role |
|---|---|---|---|---|---|
| Standard Insulin (e.g., Humalog, Lantus, Novolog, Regular) | U-100 (100 units/mL) | 1x (Baseline) | 0.5 mL | 10 mL vials, 3 mL cartridges, 3 mL disposable pens | Standard replacement therapy for Type 1 and Type 2 diabetes. |
| Humalog KwikPen / Lyumjev | U-200 (200 units/mL) | 2x as concentrated | 0.25 mL | 3 mL disposable KwikPen (600 units total per pen) | Rapid mealtime insulin for patients requiring high mealtime doses with smaller injection volumes. |
| Tresiba FlexTouch | U-200 (200 units/mL) | 2x as concentrated | 0.25 mL | 3 mL disposable FlexTouch pen (600 units total per pen) | Ultra-long basal insulin; delivers up to 160 units in a single injection. |
| Toujeo SoloStar / Max SoloStar | U-300 (300 units/mL) | 3x as concentrated | 0.167 mL | 1.5 mL SoloStar (450 units total), 3 mL Max SoloStar (900 units total) | Concentrated glargine providing a more compact depot and flatter 24-hour basal release profile. |
| Humulin R U-500 | U-500 (500 units/mL) | 5x as concentrated | 0.10 mL | 20 mL vial (10,000 units total), 3 mL KwikPen (1,500 units total) | Severe insulin resistance (>200 units/day); extreme high-alert medication. |
3. Humulin R U-500: Extreme High-Alert Precautions
Humulin R U-500 is five times more concentrated than standard U-100 insulin. Because 1 unit of U-500 contains the insulin mass of 5 units of U-100 in just 0.002 mL, any dosing or calculation error produces catastrophic consequences.
┌────────────────────────────────────────────────────────────────────────┐
│ HUMULIN R U-500 CONCENTRATION MATH │
├────────────────────────────────────────────────────────────────────────┤
│ • 1 mL = 500 units of insulin │
│ • 0.1 mL = 50 units of insulin │
│ • 0.01 mL = 5 units of insulin │
│ • 0.002 mL = 1 unit of insulin │
│ │
│ FATAL TRAP: If a nurse uses a standard U-100 syringe to draw U-500 │
│ insulin up to the '50 unit' mark, the patient receives 250 UNITS │
│ (a 5-fold massive overdose precipitating fatal hypoglycemia)! │
└────────────────────────────────────────────────────────────────────────┘
Mandatory Safeguards for Humulin R U-500
- Dedicated Green-Striped U-500 Syringe: If dispensing U-500 vials, the pharmacy must ONLY dispense dedicated U-500 syringes manufactured with a green needle shield, green plunger flange, and bold green volumetric markings. The syringe is calibrated directly in 5-unit increments up to 250 units (0.5 mL). Standard U-100 syringes or tuberculin (TB) syringes must NEVER be used.
- Dedicated U-500 KwikPen: The prefilled Humulin R U-500 KwikPen dials directly in 5-unit increments. The pen automatically measures the correct volume, completely eliminating mathematical conversion errors.
- Patient & Caregiver Counseling: The technician must confirm that the patient has received explicit counseling from the pharmacist on using only green U-500 syringes and recognizing the green box packaging.
4. The Cardinal Pen-vs-Vial Safety Rule
A critical exam concept and real-world safety rule governs concentrated insulin pens:
[!CAUTION] The Absolute Pen Safety Mandate: Insulin pen devices (U-100, U-200, U-300, U-500) are engineered to automatically dial and deliver the exact number of UNITS dialed, regardless of the concentration inside the cartridge.
NEVER WITHDRAW INSULIN FROM A PEN CARTRIDGE WITH AN EXTERNAL SYRINGE!
Why Drawing from a Pen with a Syringe Is Fatal
If a patient or nurse inserts an external U-100 syringe into a Toujeo U-300 or Humalog U-200 pen cartridge to draw a dose:
- The pen dials in actual units (e.g., dialing 30 on a U-200 pen automatically dispenses 0.15 mL, which contains exactly 30 units).
- If a practitioner uses a standard U-100 syringe and draws fluid to the "30 unit mark" (which is 0.3 mL), that 0.3 mL of U-200 insulin actually contains 60 UNITS OF INSULIN (a 100% overdose).
- If drawn from a Toujeo U-300 pen to the "30 unit mark" (0.3 mL), the syringe contains 90 UNITS OF INSULIN (a 300% / 3-fold overdose).
┌─────────────────────────────────────────────────────────────────────────────┐
│ THE FATAL EXTERNAL SYRINGE TRAP │
├─────────────────────────────────────────────────────────────────────────────┤
│ Prescribed: 40 units of Toujeo (U-300 glargine) │
│ │
│ Correct Pen Method: │
│ Dial pen to '40' → Injects 0.133 mL → Delivers exactly 40 units. │
│ │
│ Fatal External Syringe Error: │
│ Draw to '40 unit' mark on U-100 syringe (0.40 mL) from Toujeo cartridge │
│ Math: 0.40 mL × 300 units/mL = 120 UNITS DELIVERED (3x Lethal Overdose!) │
└─────────────────────────────────────────────────────────────────────────────┘
5. Insulin Syringe Calibrations and Selection
When dispensing insulin vials, verifying technicians must ensure that the selected syringe barrel capacity matches the patient's individual dose to optimize measurement accuracy and visual legibility.
| Syringe Size (U-100) | Maximum Dose Capacity | Graduation Markings | Best Suited Clinical Dosing Range |
|---|---|---|---|
| 0.3 mL Syringe | 30 Units | 0.5-unit or 1-unit markings | Doses up to 30 units (ideal for pediatric, elderly, and small fractional doses) |
| 0.5 mL Syringe | 50 Units | 1-unit markings | Doses between 31 and 50 units |
| 1.0 mL Syringe | 100 Units | 1-unit or 2-unit markings | Doses between 51 and 100 units |
| Dedicated U-500 Syringe | 250 Units (0.5 mL) | 5-unit green markings | Specifically for Humulin R U-500 vial administration only |
[!WARNING] Prohibition of Tuberculin (TB) Syringes: Tuberculin syringes are calibrated in milliliters (0.01 mL increments) rather than insulin units. Measuring U-100 or U-500 insulin in a TB syringe requires manual mathematical decimal conversion (e.g., calculating that 24 units of U-100 = 0.24 mL), which historically carries an unacceptably high rate of 10-fold decimal errors. TB syringes are strictly contraindicated for insulin measurement.
6. Storage, In-Use Beyond-Use Dating (BUD), and Temperature Limits
Insulin is a delicate protein that rapidly denatures and loses potency when exposed to excessive heat, light, agitation, or freezing temperatures.
Unopened / Stock Storage
- Refrigeration: Store unopened vials and pens in the refrigerator at 2°C to 8°C (36°F to 46°F).
- Manufacturer Expiration: Unopened refrigerated insulin remains stable until the manufacturer's printed expiration date on the carton/vial.
- Never Freeze: Frozen insulin undergoes irreversible peptide aggregation; any insulin that has frozen must be discarded immediately, even if thawed.
Opened / In-Use Room Temperature Beyond-Use Dating (BUD)
Once an insulin vial or pen is removed from refrigeration and punctured or placed into service at room temperature (up to 25°C / 77°F, maximum 30°C / 86°F), the manufacturer beyond-use date begins. Room temperature BUD varies drastically across products:
| Room Temp BUD | Specific Insulin Products & Delivery Forms | |---|---|| | 10 Days | • Humulin 70/30 Pen<br/>• Humalog Mix 75/25 Pen<br/>• Humalog Mix 50/50 Pen | | 14 Days | • Humulin N Pen<br/>• Novolog Mix 70/30 Pen | | 28 Days (Standard) | • Lantus (glargine U-100) Vials & SoloStar Pens<br/>• Basaglar / Semglee (glargine U-100) KwikPens<br/>• Humalog (lispro U-100, U-200) Vials & KwikPens<br/>• Novolog / Fiasp (aspart) Vials & FlexTouch Pens<br/>• Apidra (glulisine) Vials & SoloStar Pens<br/>• Novolin N Pens<br/>• Humalog Mix 75/25 & 50/50 Vials<br/>• Novolog Mix 70/30 Vials<br/>• Humulin R U-500 KwikPens | | 31 Days | • Humulin R (U-100) Vials<br/>• Humulin N (U-100) Vials<br/>• Humulin 70/30 Vials | | 40 Days | • Humulin R U-500 Vials | | 42 Days (6 Weeks) | • Levemir (detemir) Vials & FlexTouch Pens<br/>• Novolin R, Novolin N, & Novolin 70/30 Vials | | 56 Days (8 Weeks) | • Toujeo (glargine U-300) SoloStar & Max SoloStar Pens<br/>• Tresiba (degludec U-100, U-200) Vials & FlexTouch Pens |
A patient presents a new prescription for Humulin R U-500 insulin vials with directions to inject 150 units subcutaneously twice daily before meals. Which of the following dispensing and verification protocols is mandatory for this prescription?
A clinic nurse contacts the pharmacy asking if they can use a standard U-100 insulin syringe to withdraw 45 units of insulin from a Toujeo SoloStar (insulin glargine U-300) disposable pen cartridge for an inpatient. What is the correct response?
A community pharmacy technician is verifying patient labels and beyond-use dates (BUD) for opened insulin products kept at room temperature (up to 25°C). Which of the following insulin products maintains the longest room-temperature stability of 56 days?
During product verification of an order for 24 units of Humulin N (NPH insulin) subcutaneous injection once daily at bedtime, the technician inspects the stock vial and supplies. Which visual characteristics and supplies are correct for this order?